Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This phase 2 study is developed to evaluate the effect of ELAD on overall survival (OS) in subjects with acute liver failure (ALF) compared to matched historical controls.
Epistemonikos ID: dfd2c144bdf67f1d975abe604aa77dfbaba38adc
First added on: May 11, 2024